Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease
Top Cited Papers
- 1 September 2001
- journal article
- clinical trial
- Published by Elsevier in Kidney International
- Vol. 60 (3), 1131-1140
- https://doi.org/10.1046/j.1523-1755.2001.0600031131.x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathiesKidney International, 1998
- Effect of Angiotensin-Converting Enzyme Inhibitors on the Progression of Nondiabetic Renal DiseaseAnnals of Internal Medicine, 1997
- Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathyThe Lancet, 1997
- Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal InsufficiencyNew England Journal of Medicine, 1996
- Proteinuria and blood pressure as causal components of progression to end-stage renal failureNephrology Dialysis Transplantation, 1996
- Blood Pressure Control, Proteinuria, and the Progression of Renal DiseaseAnnals of Internal Medicine, 1995
- Effect of Captopril on Progression to Clinical Proteinuria in Patients With Insulin-Dependent Diabetes Mellitus and MicroalbuminuriaJAMA, 1994
- Long-Term Benefits of the Antiproteinuric Effect of Angiotensin-Converting Enzyme Inhibition in Nondiabetic Renal DiseaseAmerican Journal of Kidney Diseases, 1993
- Long-term comparison between captopril and nifedipine in the progression of renal insufficiencyKidney International, 1992
- Renal protective effect of enalapril in diabetic nephropathy.BMJ, 1992